Chen, Li
Yang, Yang
Chen, Junwei
Lin, Yinghong
Xian, Liang
Chen, Yuhui
Zhu, Xingshu
Tang, Ying
Zuo, Yi
Xia, Shaohuai
Xia, Xuewei
Xu, Yongjun
Wang, Shousen
Funding for this research was provided by:
Joint Logistics Medical Key Specialty Program (LQZD-SW)
Article History
Received: 4 February 2025
Accepted: 15 August 2025
First Online: 7 October 2025
Declarations
:
: This study: Intranasal delivery of hypoxia-preconditioned extracellular vesicles derived from BMSCs requires alleviates neuroinflammation and brain dysfunction in TBI, “has been approved by the Animal Ethics Committee of Fuzong Clinical Medical College of Fujian Medical University. (Approval No. 2024-05, approved on May 22, 2024).
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.